true

Cure Brain Cancer Foundation is the major funder of brain cancer research in Australia. Our Foundation funds research grants designed to improve survival outcomes for people with brain cancer, including project grants and fellowships. 

Mid-Career Fellowships

Applications open Friday 4 February 2022, 9am AEDT

Applications close Friday 8 April 2022, 5pm AEST

 

To improve survival and quality of life for people with brain cancer, we need the most talented and brilliant minds working in this area. For the first time, Cure Brain Cancer Foundation is launching a Mid-Career Fellowship round as part of our Brilliant Minds program, which aims to attract and support the brightest minds to work in brain cancer.

Cure Brain Cancer Foundation’s Mid-Career Fellowships will support mid-career researchers undertaking high quality research to retain talented individuals in the field of brain cancer.  

It is expected that Fellows undertake a significant piece of publishable work during their tenure that will lead to a more permanent position within the brain cancer research field.

Funding Details

Cure Brain Cancer Foundation’s Mid-Career Fellowships will offer grants-in-aid of up to $420,000 over three years. This includes up to $120,000 salary (depending on experience and academic level), $15,000 for research consumables and $5,000 for travel and conferences per year.

Eligibility

Applicants must:

  • Be eligible to work in Australia or New Zealand for the duration of the award.
  • Undertake research at an Australian or New Zealand institution.
  • Have been awarded their PhD within the last 6-15 years. Not concurrently hold a Fellowship from another funding body.
  • Have a proven track record of research and have demonstrated evidence of translational research capacity but should not hold a full Professional position (including Adjunct, Clinical, Conjoint, Honorary etc. positions) by an institution.
  • Have read and agree to the terms and conditions of funding.

Process

  • Applications open Friday 4 February 2022, 9am AEDT
  • Applications close Friday 8 April 2022, 5pm AEST
  • Short-listed applicants notified for virtual interviews in June 2022
  • Virtual interviews with Cure Brain Cancer Foundation’s Scientific Advisory Committee in June 2022

 

Apply online via Cure Brain Cancer Foundation’s Grant Portal

Read the Assessment Criteria used to rank applications for Cure Brain Cancer Foundation funding.

Cure Brain Cancer Foundation is dedicated to ensuring that all eligible researchers have an equal opportunity to participate in the Foundation's grant funding schemes. You can read our Equal Opportunity Statement here.

 

Clinical Accelerator

Applications open Thursday 21 October, 9am AEDT

Applications close Friday 3 December, 5pm AEDT

 

 

Cure Brain Cancer Foundation has launched the world’s largest brain cancer-dedicated Clinical Accelerator. This program will pilot in 2021, with the intention of establishing an annual competition which is subject to funding available and program success.

The Clinical Accelerator aims to progress ideas from early-stage, pre-clinical research, into a therapeutic product that shows proof of concept and viability for industry partnership and investment. The program will de-risk investment for pharmaceutical and biotechnology companies, to encourage them to develop their most promising agents in brain cancer and enables leading researchers to advance their pioneering ideas into clinical development.

The Clinical Accelerator program is part of the Foundation’s commitment to accelerate new treatments to patients as quickly as possible.

 

Funding Details

This year’s Clinical Accelerator will offer up to AUD2 million in funding support.

The amount of funding distributed will be dependent on the calibre of applications received, and the number of applications proposed for funding. Under this scheme, one or more proposals, with an aggregate maximum value of AUD2 million, could be funded.

 

Eligibility

Eligible applicants include:

  • Australian and New Zealand-based researchers with development projects in primary brain cancer.
  • Biotechnology and pharmaceutical companies with an Australian or New Zealand business number, with development projects in primary brain cancer.

Eligible projects include pre-clinical research with proof-of-concept and the potential for translation into the clinic within three to four years, and early-stage clinical trials.

Applicants must:

Members of Cure Brain Cancer Foundation’s Board of Directors and Scientific Advisory Committee are ineligible to apply under this scheme. 

 

Process

The program will pilot in 2021 and will be overseen by the Foundation’s world-leading Scientific Advisory Committee.

1. Expressions of Interest – open 21 October and close 3 December 2021

    Apply online via Cure Brain Cancer Foundation’s Grant Portal

  • All applicants must complete a non-disclosure agreement with Cure Brain Cancer Foundation prior to submitting an application*. The agreement template is provided as part of the application, via the Foundation’s Grant Portal.

2. Applications will be evaluated by the Foundation’s Scientific Advisory Committee (“SAC”).

3. January 2022: Top applicants will be notified and invited to submit a more detailed proposal/development plan, including an optional economic propositions document**, followed by a 15-minute virtual presentation to the SAC in March 2022.

4. The SAC will recommend the applicant(s) to receive Foundation funding based on the Assessment Criteria.

5. Where an application has been scientifically recommended by the SAC, and the relevant applicant has also submitted an economic proposition, then that proposition shall be evaluated by an Investment Committee, consisting of relevantly qualified members of the Foundation’s SAC and commercial experts with industry and financial experience in supporting early-stage companies and/or research, to make a final funding recommendation.

6. In the event that:

  • the application(s) recommended by the SAC is(are) not accompanied by an economic proposition(s) then the final funding decision will be made by the SAC;
  • the application(s) recommended by the SAC is(are) accompanied by an economic proposition(s) then the final funding decision will be made by the Investment Committee.

A final funding decision is expected to occur by April 2022.

*All sensitive and confidential information, including detail on IP, will be treated as such and shared solely with the Foundation’s Scientific Advisory Committee and essential Foundation staff involved in the operations and management of the competition. The Foundation’s Board of Directors and general Foundation staff will not have access to any such information.

** Economic propositions are intended to support future Cure Brain Cancer Foundation research investments and support functions for the brain cancer community. This optional document will outline potential economic returns to the Foundation, should the developmental products funded by Cure Brain Cancer Foundation, through its Clinical Accelerator program, progress to commercialisation.

 

Apply online via Cure Brain Cancer Foundation’s Grant Portal

 

Cure Brain Cancer Foundation is dedicated to ensuring that all eligible researchers have an equal opportunity to participate in the Foundation's grant funding schemes. Read our Equal Opportunity Statement 

  

Read our Terms and Conditions of Funding here.

 

back-to-top